In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

RNA vaccine technology has emerged as a groundbreaking approach in the field of immunology and infectious disease prevention.

In two experiments, researchers have found that introducing people to "mental models" about how mRNA vaccination works and ...

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...